MFS
CORT icon

Mirabella Financial Services’s Corcept Therapeutics CORT Stock Holding History

Mirabella Financial Services’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Sell
3,009
-7,179
-70% -$433K 0.03% 515
2026
Q1 		$411K Buy
+10,188
New +$381K 0.04% 341

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirabella Financial Services's CORT Position: Q2 2026 in Review

Mirabella Financial Services reduced its Corcept Therapeutics (CORT) stake by 70% in Q2 2026, selling an estimated $433K and leaving 3,009 shares worth $262K. The position accounts for 0.03% of the portfolio, ranked #515.

Mirabella Financial Services first reported a position in CORT in Q1 2026 and has held it in 2 quarters since. The position peaked at $411K in Q1 2026. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Mirabella Financial Services held 3,009 shares of Corcept Therapeutics worth $262K as of Q2 2026.
  • Mirabella Financial Services sold 7,179 Corcept Therapeutics shares in Q2 2026, an estimated $433K.
  • Corcept Therapeutics made up 0.03% of Mirabella Financial Services's portfolio in Q2 2026, its #515 holding.
  • Mirabella Financial Services first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Mirabella Financial Services's Corcept Therapeutics position peaked at $411K in Q1 2026.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.